期刊文献+

经导管植入式主动脉人工心脏瓣膜的研究进展

The Research Progress of Transcatheter Aortic Valve Replacement
下载PDF
导出
摘要 经导管植入式主动脉人工心脏瓣膜的研发日益增多,该文对目前该类产品的研究进展进行了总结,同时对境内临床试验的开展提出了初步建议。 During the past years transcatheter aortic valve replacement has evolved to a promising technique for the treatment of the patients who suffered from severe aortic stenosis, the progress and basic consideration on clinical study have been summarized in the article.
出处 《中国医疗器械杂志》 CAS 2014年第5期350-352,共3页 Chinese Journal of Medical Instrumentation
关键词 经导管植入式主动脉人工心脏瓣膜 研究进展 临床试验 transcatheter aortic valve replacement, research progress, clinical trial
  • 相关文献

参考文献14

  • 1Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery[J]. N Engl J Med, 2010, 363(17): 1597-1607.
  • 2Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs[J]. Eur Heart J, 1992, 13(5): 704-708.
  • 3Cribier A, Eltehaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis lbr calcific aortic stenosis: first human case description[J]. Circulation, 2002, 106(24): 3006- 3008.
  • 4Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study[J]. Circulation, 2006, 114( 15): 1616-1624.
  • 5杨跃进.经导管主动脉瓣置入术的现状及展望[J].中国循环杂志,2013,28(3):161-163. 被引量:12
  • 6FDA. The Edwards SAPIEN THV transcatheter heart valve system for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery [EB/OL]. [2011-07-20]. http://www.fda.gov/downloads/advisorycommittees/ committeesmeetingmaterials/medicaldevices/medicaldev- icesadvisorycornmittee/circulatorysystemdevicespanel/ucm262935.pdf.
  • 7FDA. Summary of safety and effectiveness data [EB/OL]. [2014-01- 17]. http://www.accessdata.fda.gov/cdrh docs/pdfl 3/P 130021 b.pdf.
  • 8Bosto,; Scientific announcesfirst commercial implants of the Lotus valve system in Europe [EB/OL]. [2013-11-15]. http://news. bostonscientific.com/2013-11-15-Boston-Scientific-Announces- First-Commercial-lmplants-Of-T-he-Lotus-Valve-System-in- Europe.
  • 9李则.国产瓣膜成功置入[J].中国医院院长,2012,8(19):38-38. 被引量:1
  • 10Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012)[J]. Eur H earl J, 2012, 33(19): 2451-2496.

二级参考文献15

  • 1Cribier A, Ehchaninoff H, Bash A, et ah Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis First Human Case Description. Circulation, 2002, 106:3006-3008.
  • 2NkomoVT, Gardin JM, SkehonTN, et al.Burden of valvular heart diseases: a population-based study. Lancet, 2006, 368:1005-1011.
  • 3Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med, 2010, 363:1597-1607.
  • 4Smith CR, Leon MB, Mack M J, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Eng! J Med, 2011,364:2187-2198.
  • 5Thomas M, Schymik G, Wahher T, et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation, 2011,124: 425-433.
  • 6Thomas M, Schymik G, Wahher T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation, 2010, 122:62-69.
  • 7Ussia GP, Barbanti M, Petronio AS, et al. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J, 2012, 33:969-976.
  • 8Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-rlsk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coil Cardiol, 2011, 58:2130-2138.
  • 9Kappetein AP, Head SJ, Treede H, et al. What is the evidence allowing us to state that transcatheter aortic valve replacement via the femoral artery is a more attractive option compared to transapical valve replacement? EuroIntervention, 2011,7:903-904.
  • 10Gurvitch R, Wood DA, Tay EL, et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation, 2010, 122: 1319-1327.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部